Listed

Unicycive Therapeutics, Inc.

UNCYNasdaqCIK 1766140HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2023
Operating income−$10.1m, Q2 FY2026
Net income−$1.7m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-13, accession 0001213900-24-097118. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-31, accession 0001213900-25-025828. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m3.4Research and development, Q3 FY2023, three months to 2023-09-30$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figure4.2Research and development, Q4 FY2023, three months to 2023-12-31$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001213900-25-025828. Derived: 12-month figure less the 9-month figure.Report this figure6.8Research and development, Q1 FY2024, three months to 2024-03-31$6.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure4.9Research and development, Q2 FY2024, three months to 2024-06-30$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure3.0Research and development, Q3 FY2024, three months to 2024-09-30$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure5.3Research and development, Q4 FY2024, three months to 2024-12-31$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure2.2Research and development, Q1 FY2025, three months to 2025-03-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure1.8Research and development, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure3.0Research and development, Q3 FY2025, three months to 2025-09-30$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure2.3Research and development, Q4 FY2025, three months to 2025-12-31$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure1.6Research and development, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure2.8Research and development, Q2 FY2026, three months to 2026-06-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure
Selling, general and administrative$m0.5Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$479.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2023-11-14, accession 0001213900-23-086979.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(5.9)Operating income, Q3 FY2023, three months to 2023-09-30−$5.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figure(6.3)Operating income, Q4 FY2023, three months to 2023-12-31−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001213900-25-025828. Derived: 12-month figure less the 9-month figure.Report this figure(9.2)Operating income, Q1 FY2024, three months to 2024-03-31−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure(7.4)Operating income, Q2 FY2024, three months to 2024-06-30−$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure(6.3)Operating income, Q3 FY2024, three months to 2024-09-30−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure(9.3)Operating income, Q4 FY2024, three months to 2024-12-31−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure(8.0)Operating income, Q1 FY2025, three months to 2025-03-31−$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure(7.0)Operating income, Q2 FY2025, three months to 2025-06-30−$7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure(7.3)Operating income, Q3 FY2025, three months to 2025-09-30−$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure(7.2)Operating income, Q4 FY2025, three months to 2025-12-31−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure(8.4)Operating income, Q1 FY2026, three months to 2026-03-31−$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure(10.1)Operating income, Q2 FY2026, three months to 2026-06-30−$10.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$18.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001213900-23-086979.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$19.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-28, accession 0001213900-24-027202. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$20.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-13, accession 0001213900-24-042298.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$16.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$15.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$20.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$15.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$13.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$15.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$27.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Net income$m(4.3)Net income, Q3 FY2023, three months to 2023-09-30−$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figure(7.8)Net income, Q4 FY2023, three months to 2023-12-31−$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001213900-25-025828. Derived: 12-month figure less the 9-month figure.Report this figure(21.0)Net income, Q1 FY2024, three months to 2024-03-31−$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure9.9Net income, Q2 FY2024, three months to 2024-06-30$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure(4.1)Net income, Q3 FY2024, three months to 2024-09-30−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure(21.5)Net income, Q4 FY2024, three months to 2024-12-31−$21.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure0.6Net income, Q1 FY2025, three months to 2025-03-31$570.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure(6.4)Net income, Q2 FY2025, three months to 2025-06-30−$6.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure(6.0)Net income, Q3 FY2025, three months to 2025-09-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure(14.7)Net income, Q4 FY2025, three months to 2025-12-31−$14.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure(12.8)Net income, Q1 FY2026, three months to 2026-03-31−$12.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure(1.7)Net income, Q2 FY2026, three months to 2026-06-30−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure
Diluted EPS$ per share(0.13)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figurenot reported(0.61)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure(1.50)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure(0.46)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figurenot reported(0.50)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure(0.52)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure(0.33)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figurenot reported(0.54)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure(0.06)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure
Basic EPS$ per share(0.13)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figurenot reported(0.61)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure0.80Basic EPS, Q2 FY2024, three months to 2024-06-30$0.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure(0.46)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figurenot reported0.04Basic EPS, Q1 FY2025, three months to 2025-03-31$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure(0.52)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure(0.33)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figurenot reported(0.54)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure(0.06)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure

Balance sheet

Cash and equivalents$44.2m, Q2 FY2026
Shareholders' equity$53.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m14.3Cash and equivalents, Q3 FY2023, at 2023-09-30$14.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001213900-23-086979.Report this figure9.7Cash and equivalents, FY2023, at 2023-12-31$9.7m. XBRL concept us-gaap:Cash. 10-K filed 2025-03-31, accession 0001213900-25-025828.Report this figurenot reportednot reportednot reported26.1Cash and equivalents, FY2024, at 2024-12-31$26.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001213900-26-035903.Report this figure19.8Cash and equivalents, Q1 FY2025, at 2025-03-31$19.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure22.3Cash and equivalents, Q2 FY2025, at 2025-06-30$22.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure42.7Cash and equivalents, Q3 FY2025, at 2025-09-30$42.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure29.2Cash and equivalents, FY2025, at 2025-12-31$29.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure37.4Cash and equivalents, Q1 FY2026, at 2026-03-31$37.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure44.2Cash and equivalents, Q2 FY2026, at 2026-06-30$44.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure
Current assets$m18.6Current assets, Q3 FY2023, at 2023-09-30$18.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001213900-23-086979.Report this figure13.4Current assets, FY2023, at 2023-12-31$13.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001213900-25-025828.Report this figure51.7Current assets, Q1 FY2024, at 2024-03-31$51.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001213900-24-042298.Report this figure44.1Current assets, Q2 FY2024, at 2024-06-30$44.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-068565.Report this figure37.7Current assets, Q3 FY2024, at 2024-09-30$37.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figure30.9Current assets, FY2024, at 2024-12-31$30.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001213900-26-035903.Report this figure27.3Current assets, Q1 FY2025, at 2025-03-31$27.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure29.5Current assets, Q2 FY2025, at 2025-06-30$29.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure50.3Current assets, Q3 FY2025, at 2025-09-30$50.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure49.0Current assets, FY2025, at 2025-12-31$49.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure63.5Current assets, Q1 FY2026, at 2026-03-31$63.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure71.3Current assets, Q2 FY2026, at 2026-06-30$71.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure
Total assets$m19.4Total assets, Q3 FY2023, at 2023-09-30$19.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001213900-23-086979.Report this figure14.2Total assets, FY2023, at 2023-12-31$14.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001213900-25-025828.Report this figure52.4Total assets, Q1 FY2024, at 2024-03-31$52.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001213900-24-042298.Report this figure44.7Total assets, Q2 FY2024, at 2024-06-30$44.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001213900-24-068565.Report this figure38.6Total assets, Q3 FY2024, at 2024-09-30$38.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figure31.7Total assets, FY2024, at 2024-12-31$31.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001213900-26-035903.Report this figure27.9Total assets, Q1 FY2025, at 2025-03-31$27.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure30.0Total assets, Q2 FY2025, at 2025-06-30$30.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure50.6Total assets, Q3 FY2025, at 2025-09-30$50.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure49.1Total assets, FY2025, at 2025-12-31$49.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure64.4Total assets, Q1 FY2026, at 2026-03-31$64.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure72.0Total assets, Q2 FY2026, at 2026-06-30$72.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure
Current liabilities$m15.5Current liabilities, Q3 FY2023, at 2023-09-30$15.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001213900-23-086979.Report this figure17.5Current liabilities, FY2023, at 2023-12-31$17.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001213900-25-025828.Report this figure30.3Current liabilities, Q1 FY2024, at 2024-03-31$30.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001213900-24-042298.Report this figure13.1Current liabilities, Q2 FY2024, at 2024-06-30$13.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-068565.Report this figure10.5Current liabilities, Q3 FY2024, at 2024-09-30$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figure24.1Current liabilities, FY2024, at 2024-12-31$24.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001213900-26-035903.Report this figure16.7Current liabilities, Q1 FY2025, at 2025-03-31$16.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure13.6Current liabilities, Q2 FY2025, at 2025-06-30$13.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure13.1Current liabilities, Q3 FY2025, at 2025-09-30$13.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure18.9Current liabilities, FY2025, at 2025-12-31$18.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure26.5Current liabilities, Q1 FY2026, at 2026-03-31$26.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure18.7Current liabilities, Q2 FY2026, at 2026-06-30$18.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure
Total liabilities$m16.0Total liabilities, Q3 FY2023, at 2023-09-30$16.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001213900-23-086979.Report this figure18.0Total liabilities, FY2023, at 2023-12-31$18.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001213900-25-025828.Report this figure30.7Total liabilities, Q1 FY2024, at 2024-03-31$30.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001213900-24-042298.Report this figure13.4Total liabilities, Q2 FY2024, at 2024-06-30$13.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001213900-24-068565.Report this figure10.7Total liabilities, Q3 FY2024, at 2024-09-30$10.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figure24.2Total liabilities, FY2024, at 2024-12-31$24.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001213900-26-035903.Report this figure16.7Total liabilities, Q1 FY2025, at 2025-03-31$16.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure13.6Total liabilities, Q2 FY2025, at 2025-06-30$13.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure13.1Total liabilities, Q3 FY2025, at 2025-09-30$13.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure18.9Total liabilities, FY2025, at 2025-12-31$18.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure26.7Total liabilities, Q1 FY2026, at 2026-03-31$26.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure18.8Total liabilities, Q2 FY2026, at 2026-06-30$18.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure
Shareholders' equity$m3.4Shareholders' equity, Q3 FY2023, at 2023-09-30$3.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figure(3.8)Shareholders' equity, FY2023, at 2023-12-31−$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001213900-26-035903.Report this figure(24.5)Shareholders' equity, Q1 FY2024, at 2024-03-31−$24.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure(14.8)Shareholders' equity, Q2 FY2024, at 2024-06-30−$14.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure(27.9)Shareholders' equity, Q3 FY2024, at 2024-09-30−$27.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure7.4Shareholders' equity, FY2024, at 2024-12-31$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure11.3Shareholders' equity, Q1 FY2025, at 2025-03-31$11.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure16.4Shareholders' equity, Q2 FY2025, at 2025-06-30$16.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure37.5Shareholders' equity, Q3 FY2025, at 2025-09-30$37.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure30.2Shareholders' equity, FY2025, at 2025-12-31$30.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure37.7Shareholders' equity, Q1 FY2026, at 2026-03-31$37.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure53.3Shareholders' equity, Q2 FY2026, at 2026-06-30$53.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure

Cash flow

Operating cash flow−$7.6m, Q2 FY2026
Capital expenditure−$1.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(4,422)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001213900-24-097118. Derived: 9-month figure less the 6-month figure.Report this figure(4,439)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001213900-25-025828. Derived: 12-month figure less the 9-month figure.Report this figure(6,456)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure(6,319)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001213900-25-076007. Derived: 6-month figure less the 3-month figure.Report this figure(9,252)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001213900-25-108600. Derived: 9-month figure less the 6-month figure.Report this figure(6,548)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure(8,903)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure(8,420)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$8.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001213900-26-088013. Derived: 6-month figure less the 3-month figure.Report this figure(5,962)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001213900-25-108600. Derived: 9-month figure less the 6-month figure.Report this figure(8,032)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure(6,241)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure(7,604)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001213900-26-088013. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001213900-24-097118. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001213900-25-025828. Derived: 12-month figure less the 9-month figure.Report this figure6.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure20.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$20.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001213900-25-076007. Derived: 6-month figure less the 3-month figure.Report this figure24.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001213900-25-108600. Derived: 9-month figure less the 6-month figure.Report this figure22.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure16.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure6.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001213900-26-088013. Derived: 6-month figure less the 3-month figure.Report this figure2.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001213900-25-108600. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figure8.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure(1.0)Capital expenditure, Q2 FY2026, three months to 2026-06-30−$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001213900-26-088013. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$k100Dividends paid, Q3 FY2023, three months to 2023-09-30$100.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2023-11-14, accession 0001213900-23-086979. Derived: 9-month figure less the 6-month figure.Report this figure0.0Dividends paid, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2024-03-28, accession 0001213900-24-027202. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Dividends paid, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-12, accession 0001213900-25-108600. Derived: 9-month figure less the 6-month figure.Report this figure0.0Dividends paid, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-03-30, accession 0001213900-26-035903. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)26.92m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares15.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3015,061,995 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001213900-23-086979.Report this figure15.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3115,232,406 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001213900-24-042298.Report this figure15.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3015,234,570 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001213900-24-068565.Report this figure32.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3032,633,074 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001213900-24-097118.Report this figure34.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3134,912,692 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001213900-25-042943.Report this figure9.4Diluted shares (weighted), Q2 FY2024, three months to 2024-06-309,405,285 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001213900-25-076007.Report this figure8.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-308,894,321 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure12.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3112,383,477 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure12.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3012,302,059 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure18.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3018,065,389 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001213900-25-108600.Report this figure23.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3123,908,153 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001213900-26-054708.Report this figure26.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3026,917,266 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure

Shares outstanding: 27.86mShares outstanding, period not labelled, at 2026-08-1227,855,257 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001213900-26-088013.Report this figure at Aug 12, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.